|
1
|
Peters S, Adjei AA, Gridelli C, Reck M and
Kerr K: Metastatic non-small-cell lung cancer (NSCLC): ESMO
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 23(Suppl 7): vii56–vii64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: Models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar
|
|
3
|
Medema JP: Cancer stem cells: The
challenges ahead. Nat Cell Biol. 15:338–344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pallini R, Ricci-Vitiani L, Banna GL,
Signore M, Lombardi D, Todaro M, Stassi G, Martini M, Maira G,
Larocca LM, et al: Cancer stem cell analysis and clinical outcome
in patients with glioblastoma multiforme. Clin Cancer Res.
14:8205–8212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lopez-Ayllon BD, Moncho-Amor V, Abarrategi
A, Ibañez de Cáceres I, Castro-Carpeño J, Belda-Iniesta C, Perona R
and Sastre L: Cancer stem cells and cisplatin-resistant cells
isolated from non-small-lung cancer cell lines constitute related
cell populations. Cancer Med. 3:1099–1111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J, Guo W, Wang L, Yu L, Mei H, Fang
S, Ji P, Liu Y, Liu G and Song Q: Cisplatin-resistant osteosarcoma
cells possess cancer stem cell properties in a mouse model. Oncol
Lett. 12:2599–2605. 2016.PubMed/NCBI
|
|
7
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ,
Wu WZ and Ren ZG: Coexpression of gene Oct4 and Nanog initiates
stem cell characteristics in hepatocellular carcinoma and promotes
epithelial-mesenchymal transition through activation of Stat3/Snail
signaling. J Hematol Oncol. 8:232015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Loh YH, Wu Q, Chew JL, Vega VB, Zhang W,
Chen X, Bourque G, George J, Leong B, Liu J, et al: The Oct4 and
Nanog transcription network regulates pluripotency in mouse
embryonic stem cells. Nat Genet. 38:431–440. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He W, Li K, Wang F, Qin YR and Fan QX:
Expression of OCT4 in human esophageal squamous cell carcinoma is
significantly associated with poorer prognosis. World J
Gastroenterol. 18:712–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu X, Mazur SJ, Lin T, Appella E and Xu Y:
The pluripotency factor nanog promotes breast cancer tumorigenesis
and metastasis. Oncogene. 33:2655–2664. 2014. View Article : Google Scholar :
|
|
12
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK,
Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X,
Lu J, Fan X, Zhu S, Wang Y, et al: Knockdown of Oct4 and Nanog
expression inhibits the stemness of pancreatic cancer cells. Cancer
Lett. 340:113–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao QW, Zhou YW, Li WX, Kang B, Zhang XQ,
Yang Y, Cheng J, Yin SY, Tong Y, He JQ, et al: Akt-mediated
phosphorylation of Oct4 is associated with the proliferation of
stem-like cancer cells. Oncol Rep. 33:1621–1629. 2015.PubMed/NCBI
|
|
16
|
Lin Y, Yang Y, Li W, Chen Q, Li J, Pan X,
Zhou L, Liu C, Chen C, He J, et al: Reciprocal regulation of Akt
and Oct4 promotes the self-renewal and survival of embryonal
carcinoma cells. Mol Cell. 48:627–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bleau AM, Hambardzumyan D, Ozawa T,
Fomchenko EI, Huse JT, Brennan CW and Holland EC: PTEN/PI3K/Akt
pathway regulates the side population phenotype and ABCG2 activity
in glioma tumor stem-like cells. Cell Stem Cell. 4:226–235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YK, Zhu YL, Qiu FM, Zhang T, Chen ZG,
Zheng S and Huang J: Activation of Akt and MAPK pathways enhances
the tumorigenicity of CD133+ primary colon cancer cells.
Carcinogenesis. 31:1376–1380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Noh KH, Kim BW, Song KH, Cho H, Lee YH,
Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY, et al: Nanog
signaling in cancer promotes stem-like phenotype and immune
evasion. J Clin Invest. 122:4077–4093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rajesh E, Sankari LS, Malathi L and Krupaa
JR: Naturally occurring products in cancer therapy. J Pharm
Bioallied Sci. 7(Suppl 1): S181–S183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Walton NJ, Mayer MJ and Narbad A:
Vanillin. Phytochemistry. 63:505–515. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
King AA, Shaughnessy DT, Mure K,
Leszczynska J, Ward WO, Umbach DM, Xu Z, Ducharme D, Taylor JA,
Demarini DM, et al: Antimutagenicity of cinnamaldehyde and vanillin
in human cells: Global gene expression and possible role of DNA
damage and repair. Mutat Res. 616:60–69. 2007. View Article : Google Scholar :
|
|
23
|
Srinivasan K, Platel K and Rao MVL:
Hypotriglyceridemic effect of dietary vanillin in experimental
rats. Eur Food Res Technol. 228:103–108. 2008. View Article : Google Scholar
|
|
24
|
Imanishi H, Sasaki YF, Matsumoto K,
Watanabe M, Ohta T, Shirasu Y and Tutikawa K: Suppression of
6-TG-resistant mutations in V79 cells and recessive spot formations
in mice by vanillin. Mutat Res. 243:151–158. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang JA, Wu SL, Lo HY, Hsiang CY and Ho
TY: Vanillin inhibits matrix metalloproteinase-9 expression through
downregulation of nuclear factor-kappaB signaling pathway in human
hepatocellular carcinoma cells. Mol Pharmacol. 75:151–157. 2009.
View Article : Google Scholar
|
|
26
|
Lirdprapamongkol K, Sakurai H, Suzuki S,
Koizumi K, Prangsaengtong O, Viriyaroj A, Ruchirawat S, Svasti J
and Saiki I: Vanillin enhances TRAIL-induced apoptosis in cancer
cells through inhibition of NF-kappaB activation. In Vivo.
24:501–506. 2010.PubMed/NCBI
|
|
27
|
Lirdprapamongkol K, Sakurai H, Kawasaki N,
Choo MK, Saitoh Y, Aozuka Y, Singhirunnusorn P, Ruchirawat S,
Svasti J and Saiki I: Vanillin suppresses in vitro invasion and in
vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci.
25:57–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lirdprapamongkol K, Kramb JP,
Suthiphongchai T, Surarit R, Srisomsap C, Dannhardt G and Svasti J:
Vanillin suppresses metastatic potential of human cancer cells
through PI3K inhibition and decreases angiogenesis in vivo. J Agric
Food Chem. 57:3055–3063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bachelard-Cascales E, Chapellier M, Delay
E and Maguer-Satta V: A protocol to quantify mammary early common
progenitors from long-term mammosphere culture. Curr Protoc Stem
Cell Biol. 1:p Unit 1E. 72012.PubMed/NCBI
|
|
30
|
Amini S, Fathi F, Mobalegi J,
Sofimajidpour H and Ghadimi T: The expressions of stem cell
markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3,
Dppa4, and Esrrb in bladder, colon, and prostate cancer, and
certain cancer cell lines. Anat Cell Biol. 47:1–11. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bae S, Kim SY, Jung JH, Yoon Y, Cha HJ,
Lee H, Kim K, Kim J, An IS, Kim J, et al: Akt is negatively
regulated by the MULAN E3 ligase. Cell Res. 22:873–885. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suizu F, Hiramuki Y, Okumura F, Matsuda M,
Okumura AJ, Hirata N, Narita M, Kohno T, Yokota J, Bohgaki M, et
al: The E3 ligase TTC3 facilitates ubiquitination and degradation
of phosphorylated Akt. Dev Cell. 17:800–810. 2009. View Article : Google Scholar
|
|
33
|
Campbell PA and Rudnicki MA: Oct4
interaction with Hmgb2 regulates Akt signaling and pluripotency.
Stem Cells. 31:1107–1120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
David O, Jett J, LeBeau H, Dy G, Hughes J,
Friedman M and Brody AR: Phospho-Akt overexpression in non-small
cell lung cancer confers significant stage-independent survival
disadvantage. Clin Cancer Res. 10:6865–6871. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lecker SH, Goldberg AL and Mitch WE:
Protein degradation by the ubiquitin-proteasome pathway in normal
and disease states. J Am Soc Nephrol. 17:1807–1819. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao B, Ahmad A, Azmi AS, Ali S and Sarkar
FH: Cancer stem cells (CSCs) and mechanisms of their regulation:
Implications for cancer therapy. Curr Protoc Pharmacol.
14:p.Unit-14. 252013.
|
|
37
|
Gargini R, Cerliani JP, Escoll M, Antón IM
and Wandosell F: Cancer stem cell-like phenotype and survival are
coordinately regulated by Akt/FoxO/Bim pathway. Stem Cells.
33:646–660. 2015. View Article : Google Scholar
|
|
38
|
Yu S, Shen G, Khor TO, Kim JH and Kong AN:
Curcumin inhibits Akt/mammalian target of rapamycin signaling
through protein phosphatase-dependent mechanism. Mol Cancer Ther.
7:2609–2620. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang H, Shang X, Wu H, Gautam SC,
Al-Holou S, Li C, Kuo J, Zhang L and Chopp M: Resveratrol
downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma
cells. J Exp Ther Oncol. 8:25–33. 2009.PubMed/NCBI
|
|
40
|
Efferth T: Stem cells, cancer stem-like
cells, and natural products. Planta Med. 78:935–942. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mendoza MC, Er EE and Blenis J: The
Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation. Trends
Biochem Sci. 36:320–328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dent P: Crosstalk between ERK, AKT, and
cell survival. Cancer Biol Ther. 15:245–246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McCubrey JA, Steelman LS, Chappell WH,
Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M,
Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth,
malignant transformation and drug resistance. Biochim Biophys Acta.
1773:1263–1284. 2007. View Article : Google Scholar
|
|
44
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu CF, Liu ZX and Cantley LG: ERK
negatively regulates the epidermal growth factor-mediated
interaction of Gab1 and the phosphatidylinositol 3-kinase. J Biol
Chem. 277:19382–19388. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bhummaphan N and Chanvorachote P: Gigantol
suppresses cancer stem cell-like phenotypes in lung cancer cells.
Evid Based Complement Alternat Med. 2015:8365642015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar
|
|
48
|
Sun FF, Hu YH, Xiong LP, Tu XY, Zhao JH,
Chen SS, Song J and Ye XQ: Enhanced expression of stem cell markers
and drug resistance in sphere-forming non-small cell lung cancer
cells. Int J Clin Exp Pathol. 8:6287–6300. 2015.PubMed/NCBI
|
|
49
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang
J: The side population in human lung cancer cell line NCI-H460 is
enriched in stem-like cancer cells. PLoS One. 7:e333582012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bertolini G, Roz L, Perego P, Tortoreto M,
Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S,
et al: Highly tumorigenic lung cancer CD133+ cells
display stem-like features and are spared by cisplatin treatment.
Proc Natl Acad Sci USA. 106:16281–16286. 2009. View Article : Google Scholar
|
|
51
|
Mirza AM, Gysin S, Malek N, Nakayama K,
Roberts JM and McMahon M: Cooperative regulation of the cell
division cycle by the protein kinases RAF and AKT. Mol Cell Biol.
24:10868–10881. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Testa JR and Tsichlis PN: AKT signaling in
normal and malignant cells. Oncogene. 24:7391–7393. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dubrovska A, Kim S, Salamone RJ, Walker
JR, Maira SM, García-Echeverría C, Schultz PG and Reddy VA: The
role of PTEN/Akt/PI3K signaling in the maintenance and viability of
prostate cancer stem-like cell populations. Proc Natl Acad Sci USA.
106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xiang T, Ohashi A, Huang Y, Pandita TK,
Ludwig T, Powell SN and Yang Q: Negative regulation of Akt
activation by BRCA1. Cancer Res. 68:10040–10044. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Millimouno FM, Dong J, Yang L, Li J and Li
X: Targeting apoptosis pathways in cancer and perspectives with
natural compounds from mother nature. Cancer Prev Res (Phila).
7:1081–1107. 2014. View Article : Google Scholar
|
|
56
|
Singh P and Bast F: Screening of
multi-targeted natural compounds for receptor tyrosine kinases
inhibitors and biological evaluation on cancer cell lines, in
silico and in vitro. Med Oncol. 32:2332015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
El Khattabi I and Sharma A: Preventing p38
MAPK-mediated MafA degradation ameliorates β-cell dysfunction under
oxidative stress. Mol Endocrinol. 27:1078–1090. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Niu H, Ye BH and Dalla-Favera R: Antigen
receptor signaling induces MAP kinase-mediated phosphorylation and
degradation of the BCL-6 transcription factor. Genes Dev.
12:1953–1961. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Deschênes-Simard X, Gaumont-Leclerc MF,
Bourdeau V, Lessard F, Moiseeva O, Forest V, Igelmann S, Mallette
FA, Saba-El-Leil MK, Meloche S, et al: Tumor suppressor activity of
the ERK/MAPK pathway by promoting selective protein degradation.
Genes Dev. 27:900–915. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ley R, Balmanno K, Hadfield K, Weston C
and Cook SJ: Activation of the ERK1/2 signaling pathway promotes
phosphorylation and proteasome-dependent degradation of the
BH3-only protein, Bim. J Biol Chem. 278:18811–18816. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Rungtabnapa P, Nimmannit U, Halim H,
Rojanasakul Y and Chanvorachote P: Hydrogen peroxide inhibits
non-small cell lung cancer cell anoikis through the inhibition of
caveolin-1 degradation. Am J Physiol Cell Physiol. 300:C235–C245.
2011. View Article : Google Scholar :
|
|
62
|
Chanvorachote P, Nimmannit U, Lu Y,
Talbott S, Jiang BH and Rojanasakul Y: Nitric oxide regulates lung
carcinoma cell anoikis through inhibition of ubiquitin-proteasomal
degradation of caveolin-1. J Biol Chem. 284:28476–28484. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Pongrakhananon V, Stueckle TA, Wang HY,
O'Doherty GA, Dinu CZ, Chanvorachote P and Rojanasakul Y:
Monosaccharide digitoxin derivative sensitize human non-small cell
lung cancer cells to anoikis through Mcl-1 proteasomal degradation.
Biochem Pharmacol. 88:23–35. 2014. View Article : Google Scholar :
|
|
64
|
Pongrakhananon V, Nimmannit U, Luanpitpong
S, Rojanasakul Y and Chanvorachote P: Curcumin sensitizes non-small
cell lung cancer cell anoikis through reactive oxygen
species-mediated Bcl-2 downregulation. Apoptosis. 15:574–585. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Castor LR, Locatelli KA and Ximenes VF:
Pro-oxidant activity of apocynin radical. Free Radic Biol Med.
48:1636–1643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu J and Mori A: Antioxidant and
pro-oxidant activities of p-hydroxybenzyl alcohol and vanillin:
Effects on free radicals, brain peroxidation and degradation of
benzoate, deoxyribose, amino acids and DNA. Neuropharmacology.
32:659–669. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tai A, Sawano T, Yazama F and Ito H:
Evaluation of antioxidant activity of vanillin by using multiple
antioxidant assays. Biochim Biophys Acta. 1810:170–177. 2011.
View Article : Google Scholar
|
